Intervention

abatacept

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 12 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12

Recruiting0

Common conditions10

Lead sponsors shown10

Clinical trials

12 shown

A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid ArthritisNCT06418529 · 2024-05-15

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyNCT03733067 · 2023-11-30

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisNCT04186871 · 2020-01-07

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)NCT03737708 · 2019-02-13

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis PatientsNCT03440892 · 2017-11-01

Study of Abatacept (Orencia) to Treat Primary Biliary CirrhosisNCT02078882 · 2014-09-01

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) PatientsNCT01351480 · 2011-06-01

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid ArthritisNCT01299961 · 2011-03-01

A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating AbataceptNCT01339481 · 2011-02-01

A Cooperative Clinical Study of Abatacept in Multiple SclerosisNCT01116427 · 2010-09-01

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic AsthmaticsNCT00784459 · 2008-10-01

Phase IIIB Subcutaneous Abatacept Monotherapy StudyNCT00547521 · 2007-12-01

Common conditions

Rheumatoid Arthritis6 Rheumatoid Arthritis (RA)2 Atopic Asthma1 Autoimmune Disorder1 Chronic Cytopenia1 CTLA4 Haploinsufficency1 Multiple Sclerosis, Relapsing-Remitting1 Primary Biliary Cirrhosis1 Primary Sjögren's Syndrome1 Systemic Lupus Erythematosus1

Leading sponsors

Bristol-Myers Squibb2 National Institute of Allergy and Infectious Diseases (NIAID)2 Arthritis & Rheumatic Disease Specialties Research1 Astellas Pharma Inc1 Astellas Pharma Korea, Inc.1 Christopher Bowlus, MD1 Pfizer1 University of California, Los Angeles1 Vastra Gotaland Region1 Washington University School of Medicine1

Trial status mix

COMPLETED10

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE24

PHASE33

PHASE42

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.